Impact
4.2 million patients reached in 2025
How we count that, what it saved the health systems buying through us, and where we fell short. Reported every year in the impact report and the stakeholder letter.
In numbers
The year, line by line
Where a comparison with the year before genuinely exists, the two sit side by side. Where it does not, the figure stands alone rather than against an invented baseline.
4.2M
patients served
+453% vs 2024
The first year the marketplace ran at scale: more patients served in twelve months than in everything before it, and the first full impact report to account for how.
Where we have a comparison
- 2024
- 2025
Patients served
+453%vs 2024
The 2024 figure is calculated back from the published increase of 453%, so it is approximate.
Topline revenue growth
12×vs annualised 2024
Measured against annualised 2024. Including performance obligations the figure is 22×.
Each metric is scaled against its own two years, not against the other metrics.
The full year
- Patients served
- +453% vs 2024
- 4.2M
- Topline revenue growth
- vs annualised 2024; 22× including performance obligations
- 12×
- Average cost savings
- 22% median
- 35%
- Deals completed
- 54
- Medicines shipped
- 1,800+ t
- Marketplace offerings
- medicines and health products
- 5,000+
| Metric | 2025 | Note |
|---|---|---|
| Patients served | 4.2M | +453% vs 2024 |
| Topline revenue growth | 12× | vs annualised 2024; 22× including performance obligations |
| Average cost savings | 35% | 22% median |
| Deals completed | 54 | |
| Medicines shipped | 1,800+ t | |
| Marketplace offerings | 5,000+ | medicines and health products |
The report
Impact Report 2025
The method behind every number, country by country, and an account of what did not work.
≈760,000
patients served
approximate
The year the marketplace was built rather than measured: incorporation in Kenya, the first one-ton shipment, and the beta the 2025 numbers are counted from.
Axmed began publishing a full impact report with 2025, so 2024 is here as the baseline that year is measured against. Only the figures that were genuinely published appear below. The rest were not counted at the time, and are not estimated here to fill the table.
The full year
- Patients served
- calculated back from the published 2025 increase of 453%, so it is approximate
- ≈760,000
| Metric | 2024 | Note |
|---|---|---|
| Patients served | ≈760,000 | calculated back from the published 2025 increase of 453%, so it is approximate |
Axmed published its first full impact report for 2025. There is no report for this year.
Voices
What the people we work with say
Procurers, distributors and research institutes who have run real volume through the platform.
Through our partnership with Axmed, we have a greater impact on improving maternal and child health outcomes and ending preventable deaths in some of Africa's most under-resourced communities.
Axmed has proven that a strong model, backed by operational excellence and deep commitment, can deliver real impact even within complex environments. They have consistently demonstrated an exceptional ability to navigate the complexities of the global healthcare supply chain, developing pragmatic strategies that produce measurable and sustainable impact.
At GMRI, we engaged Axmed Global Health Advisory to work with us on the go-to-market / access strategy. Their professionalism, experience, working relationships with our teams and knowledge have been outstanding.
Read the full impact report
The method behind every number, country by country, and what we got wrong.